Ozempic face is only half of it. A dermatologist on the skin changes nobody warns you about.

Dr. Dray has seen the skin changes patients don't expect: thinner dermis, visible blood vessels, sagging vulva, and a type of fat loss researchers are just beginning to understand.

Dermatologist Explains Ozempic Face, Hair Loss & GLP-1 Skin Aging

Rapid weight loss on a GLP-1 is surprisingly easy to hit. The threshold is just one to two pounds a week, or 5% of your body weight in six months. Most people on semaglutide or tirzepatide clear that without trying.

What happens next shows up in the mirror before it shows up on the scale. Temples hollow first because the skin there is thin and has almost no fat underneath. Then the mid-face deflates. Blood vessels that were hidden under plump skin become visible. Dark circles deepen. The labia majora, the outer vulva, starts to sag and wrinkle in ways women notice when they put on leggings.

Dr. Dray, a board-certified dermatologist, has spent the past few years watching these changes accelerate in her patients and reviewing the emerging research on why GLP-1 receptor agonists seem to affect skin differently than other kinds of weight loss. Some of it is mechanical: the skin cannot retract fast enough. Some of it is structural: muscle and connective tissue disappear along with the fat. And some of it, she says, might be happening at the cellular level in a fat compartment most people have never heard of.

1. What researchers see under the microscope after massive weight loss

When scientists biopsy skin after rapid weight loss, from GLP-1s or surgery or aggressive dieting, the findings are consistent. Thick collagen density drops. Elastin density drops. Fibroblasts, the cells that make collagen, slow down. The epidermis thins. The dermis thins. The term for this is atrophy.

Collagen fibers in the deeper layers become disorganized. The skin loses firmness and elasticity. With less dermal support, the blood vessels underneath become more obvious at the surface. That shows up as more redness, more visible veins, darker under-eyes.

Patients also report dry, scaly, flaky skin. Dr. Dray attributes this to a combination of lower fluid intake, plus subclinical deficiencies in zinc and iron, which impair the skin barrier and increase water loss.

When researchers examine the skin under the microscope after a massive weight loss, they see some pretty notable findings: a decrease in thick collagen density, reduction in elastin density, a decline in fibroblast activity.Dr Dray

2. The muscle loss that makes sagging worse

Sarcopenia is the progressive loss of muscle mass, strength and function. Muscle provides structural support under the skin. When it disappears quickly, sagging and laxity become more obvious.

In standard calorie-restriction diets, about 20% to 25% of weight lost is fat-free mass, which includes muscle and connective tissue. In the STEP 1 and SURMOUNT clinical trials for semaglutide and tirzepatide, fat-free mass loss ranged from 25% up to 43%.

That is a substantial difference. It is also one of the main reasons resistance training and adequate protein intake are emphasized so heavily for people on these medications.

3. Ozempic face, quantified

Ozempic face usually refers to hollowing around the eyes, sagging skin, deflation and overall volume loss. One prospective study used CT or MRI scans of the head and neck in patients on GLP-1s and measured the changes.

Researchers found an 11% decrease in mid-face superficial fat volume, which was statistically significant. They also saw about a 7% decrease in deep facial fat, which was not statistically significant.

To put that in perspective: over roughly 11 years of natural aging, we lose about 18% of deep facial fat and 11% of superficial fat. In other words, these medications may be compressing more than a decade of facial aging into months.

4. A unique type of fat inside your skin that GLP-1s may target

DWAT stands for dermal white adipose tissue. It is a type of fat located within the skin itself, not under it. DWAT surrounds hair follicles, oil glands and the tiny muscles that give you goosebumps.

It contributes to dermal thickness, skin elasticity, facial volume and hair follicle cycling. It also plays a role in antimicrobial defense and skin regeneration. DWAT shares the same embryonic origin as dermal fibroblasts, the cells that make collagen. That makes it unique compared to other fat depots in the body.

Here is what has researchers interested: adipocyte stem cells, the precursors to fat cells, have GLP-1 receptors on their surface. Scientists theorize that GLP-1 medications might alter cellular signaling in DWAT in a way that affects local estrogen and collagen production. This has not been proven yet, but it could explain why some of the skin and hair changes seen with these drugs seem different from other types of rapid weight loss.

5. Hair loss: 76% higher odds of telogen effluvium

One large cohort analysis of more than 547,000 patients found significantly higher odds of hair loss within six to 12 months of starting a GLP-1. There was a 76% increase in telogen effluvium and 64% higher rates of androgenetic alopecia, or pattern hair loss.

Telogen effluvium is the classic stress-related shedding that happens two to four months after a trigger: a new medication, a drop in appetite, rapid weight loss. It is usually self-limited and resolves as the body adapts, though it can become chronic in some cases.

Nutritional deficiencies like low iron and vitamin D make shedding worse. And DWAT, which cushions and supports the hair follicle, may be playing a specific role in the types of hair loss seen with GLP-1 medications.

6. Rashes, itching, burning skin and nerve-related symptoms

According to the FDA's adverse event reporting system, about 8% of reported side effects from GLP-1 medications involve the skin. The most common are rash, itching, hair loss and excessive sweating.

Less common but more serious reactions include eosinophilic panniculitis, bullous pemphigoid (a blistering disorder), drug rashes, angioedema and even a case of tirzepatide-induced lichen planus pigmentosus.

There are also emerging reports of neurocutaneous symptoms: dysesthesia, paresthesia, hyperesthesia, allodynia, burning and sensitive skin. Allodynia is pain triggered by things that are not normally painful, like light touch. These tend to emerge when doses are escalated and often resolve when the medication is stopped or the dose is reduced.

7. Wound healing problems and fat necrosis after surgery

For patients with diabetes, GLP-1 medications can be lifesaving when it comes to wound healing. Diabetes seriously impairs healing and leads to infections, ulcers and amputations. These drugs can flip that script entirely.

But in non-diabetic patients, there have been reports of poor wound healing and fat necrosis after surgery. Dr. Dray suspects this is related to the rapid loss of adipose tissue, which serves as a reservoir for healing and provides vascular support. When that tissue disappears quickly, the body becomes more vulnerable.

8. Ozempic vulva: deflation, sagging and what women are noticing

The term Ozempic vulva refers to deflation, wrinkling, volume loss, sagging, dryness and looseness of the labia majora, the outer vulva. Women report that the outer vulva looks smaller and the inner labia, the labia minora, hangs lower and is more visible, even through leggings.

In 2024, there was a documented rise in interest for vulvoplasty, cosmetic surgery to reshape the vulva. It appears to be tied to these changes.

The labia majora contains DWAT, dermal white adipose tissue. This appears to be a female-specific outcome. The male genitalia, specifically the testicles, do not contain DWAT and do not seem to be affected in the same way.

9. How to minimize the damage: slow loss, resistance training, nutrients

The most important strategy is making sure weight loss is slow and steady. Extremely rapid reduction leads to muscle loss, skin laxity, sagging, hair shedding, facial volume loss and nutrient deficiencies.

Resistance training is critical. It preserves muscle mass and provides structural support under the skin. Protein intake also matters. Common recommendations fall between 1.0 and 1.2 grams of protein per kilogram of body weight per day, though individual needs vary.

Micronutrient optimization is just as important as protein. You need zinc, iron, essential fatty acids, vitamins and trace minerals. If someone is eating very little food and most of it is junk, that is bad news. Drink water too. Patients on these medications commonly forget, and dehydration has real consequences.

Dr. Dray is blunt: health is not about restricting calories. It is about nutrient quality. Stable, gradual weight loss paired with resistance training and a balanced diet that includes variety and key micronutrients is the only way to avoid the worst of these changes.

Health is not about restricting calories. It's about nutrient quality.Dr Dray

10. The ethical problem nobody is calling out

Many patients are getting GLP-1 medications not through their primary care doctor but through cosmetic clinics. It is easy to access these drugs without a physician saying, "I don't think this is a good idea. Not on my license."

Here is where the ethical issue comes in, according to Dr. Dray. These clinics are not only selling the medications to people who may not need to lose weight. They are also selling, and profiting from, the procedures used to fix the problems caused by rapid weight loss.

She breaks down the math: $500 a month for the GLP-1. $1,600 for Sculptra, a biostimulatory filler. $2,000 for ultrasound therapy. $1,500 for muscle stimulation devices. Another $1,500 for laser treatments. That adds up to more than $7,000.

"What gym membership is going to cost you more than $7,000?" she asks. She does not believe this kind of counseling is happening upfront. Instead, patients walk in asking for a GLP-1 as if they are shopping for jewelry, and the clinic has a treatment plan, and supplements, and a price tag ready to go.

It's gone from an effective drug for treating certain people who really need it to anybody and everybody and let's profit from this maximally. And that's what's happening.Dr Dray

Dr. Dray is careful to emphasize that GLP-1 receptor agonist medications are game changers for the right person. They save lives. But rapid weight loss comes with trade-offs, especially for people who may not need to lose much weight and end up losing it very quickly anyway.

If you are on one of these medications and concerned about how fast the weight is coming off, check in with your doctor. Make sure it is going at a healthy pace. In her view, no one should be getting these drugs without nutritional monitoring and counseling, ideally with a registered dietitian. You need adequate protein, but you also need zinc, iron, essential fatty acids, the whole list. And you need resistance training. No medication replaces the importance of those things. Two years from now, your skin will show you whether you got them right.

Questions people ask

What is Ozempic face and why does it happen?

Ozempic face refers to hollowing around the eyes, sagging skin and facial volume loss from rapid weight loss on GLP-1 medications. Studies show an 11% decrease in mid-face fat volume, roughly compressing more than a decade of natural facial aging into months. The skin cannot retract fast enough to accommodate the change.

Can Ozempic cause permanent hair loss?

GLP-1 medications significantly increase the odds of telogen effluvium (76% higher) and androgenetic alopecia (64% higher) within six to 12 months. Telogen effluvium is usually self-limited and resolves as the body adapts, but it can become chronic in some cases, especially with underlying nutritional deficiencies like low iron or vitamin D.

What is DWAT and why does it matter on a GLP-1?

DWAT, or dermal white adipose tissue, is a unique type of fat inside your skin that supports hair follicles, oil glands, dermal thickness and collagen production. Researchers believe GLP-1 medications may uniquely target this fat compartment because adipocyte stem cells have GLP-1 receptors on their surface, potentially altering estrogen and collagen signaling in ways that go beyond simple weight loss.

DD
Dr Dray

Dr. Dray is a board-certified dermatologist who discusses GLP-1 medications and their effects on skin, hair, and body composition. 167,738 views on the original video.

Watch the original on YouTube →

Trending Topics

Free, from GLP‑1 Classified

Thinking about a GLP‑1? Read our guide before you start.

The questions to ask, the costs nobody mentions, and what the first month really feels like. Plus a short weekly letter for people on, or considering, a GLP‑1. We are not a pharmacy or a telehealth brand. We work for you, not for them.

No spam. Unsubscribe any time.